Welcome to LookChem.com Sign In|Join Free
  • or
5-Azaspiro[2.4]heptan-4-one is a heterocyclic compound with a unique structure, featuring a nitrogen atom in place of a carbon atom in a spiro[2.4]heptane ring system. This seven-membered ring is composed of five carbon atoms and two nitrogen atoms, with the nitrogen atoms positioned at the 1st and 5th positions. The compound has a ketone functional group at the 4th position, which is crucial for its reactivity and potential applications. 5-Azaspiro[2.4]heptan-4-one is of interest in organic chemistry due to its potential use as a building block for the synthesis of more complex molecules, particularly in the development of pharmaceuticals and other specialty chemicals. Its unique structure and properties make it a subject of study for chemists exploring novel synthetic pathways and molecular architectures.

3697-70-9

Post Buying Request

3697-70-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

3697-70-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 3697-70-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,6,9 and 7 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 3697-70:
(6*3)+(5*6)+(4*9)+(3*7)+(2*7)+(1*0)=119
119 % 10 = 9
So 3697-70-9 is a valid CAS Registry Number.

3697-70-9Relevant academic research and scientific papers

NOVEL 6,7-DIHYDRO-4H-PYRAZOLO[1,5-A]PYRAZINE INDOLE-2-CARBOXAMIDES ACTIVE AGAINST THE HEPATITIS B VIRUS (HBV)

-

, (2020/05/29)

The present invention relates generally to novel antiviral agents. Specifically, the present invention relates to compounds which can inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV replication cycle, compositions comprising such compounds, methods for inhibiting HBV viral replication, methods for treating or preventing HBV infection, and processes and intermediates for mating the compounds.

HIGHLY ACTIVE CSF1R INHIBITOR COMPOUND

-

Paragraph 0113; 0136; 0139, (2020/12/10)

ABSTRACT The present invention relates to a CSF1R inhibitor, and in particular to a highly active CSF1R inhibitor compound having the structure of formula (I). Said compound of the present invention has high inhibitory activity on CSF1R.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 3697-70-9